TY - JOUR
T1 - Plasmon-Enhanced Photocatalytic Activity of Organic Heterostructure for Indoor-Light Antibacterial Therapy
AU - Jiao, Hui Feng
AU - Guo, Jiaxu
AU - Cui, Yuying
AU - Yu, Xin
AU - Liao, Yunfei
AU - Ying, Yiran
AU - Li, Zhongan
AU - Yao, Kai
AU - Huang, Haitao
N1 - Funding Information:
The authors thank Jeremy J. Intemann (University of Wisconsin‐Green Bay) for providing critical evaluation of the manuscript during revision. The authors gratefully acknowledge funding support from the National Natural Science Foundation of China (Grants 81701324, 51863013, and 61874052) and Interdisciplinary Innovation Funds of Nanchang University (9167‐28220007‐YB2102). K.Y. thanks the Excellent Young Talent Foundation of Jiangxi Province for financial support (Grant 20192BCB23009). H.J. thanks the Postdoctoral Innovation Talents Support Program (No. BX20180144) for financial support.
Publisher Copyright:
© 2021 Wiley-VCH GmbH
PY - 2022/2
Y1 - 2022/2
N2 - Semiconductor nanomaterials with photocatalytic activity have been considered as potential antibacterial materials against bacterial infection. Noble metal nanoparticles have been developed with semiconductors to promote their photocatalytic activities; however, the incorporation of noble metal NPs brings the risk of toxicity from the heavy metal species, especially for the widely used Ag nanoparticles (AgNPs). Herein, an all-organic chloridized g-C3N4/perylene-3,4,9,10-tetracarboxylic diimide (Cl-CNPD) heterostructure is chosen as a platform, in which the chloridized g-C3N4 provides bonding sites for uniform loading of AgNPs to prepare a plasmonic antibacterial nanocomposite. Benefiting from the in situ implanting approach, plasmon-induced light manipulation from the homodispersed AgNPs enables the nanocomposites to produce more reactive oxygen species (ROS), resulting in an antibacterial efficacy up to 96.1 ± 1.4% and 91.5 ± 1.8% against Staphylococcus aureus (S. aureus) under simulated sunlight (20 mW cm−2) and indoor light (5 mW cm−2) irradiation within 20 min, respectively, much higher than that of the organic heterostructure. Moreover, the strong interaction between the AgNPs and Cl-CNPD not only guarantees negligible toxicity by minimizing Ag leakage, but also shows high durability with unchanged efficacy after challenging bacteria up to five times repeatedly. Therefore, this confined plasmonic-based antibacterial nanocomposite shows great potential as a safe therapeutic system for wound disinfection.
AB - Semiconductor nanomaterials with photocatalytic activity have been considered as potential antibacterial materials against bacterial infection. Noble metal nanoparticles have been developed with semiconductors to promote their photocatalytic activities; however, the incorporation of noble metal NPs brings the risk of toxicity from the heavy metal species, especially for the widely used Ag nanoparticles (AgNPs). Herein, an all-organic chloridized g-C3N4/perylene-3,4,9,10-tetracarboxylic diimide (Cl-CNPD) heterostructure is chosen as a platform, in which the chloridized g-C3N4 provides bonding sites for uniform loading of AgNPs to prepare a plasmonic antibacterial nanocomposite. Benefiting from the in situ implanting approach, plasmon-induced light manipulation from the homodispersed AgNPs enables the nanocomposites to produce more reactive oxygen species (ROS), resulting in an antibacterial efficacy up to 96.1 ± 1.4% and 91.5 ± 1.8% against Staphylococcus aureus (S. aureus) under simulated sunlight (20 mW cm−2) and indoor light (5 mW cm−2) irradiation within 20 min, respectively, much higher than that of the organic heterostructure. Moreover, the strong interaction between the AgNPs and Cl-CNPD not only guarantees negligible toxicity by minimizing Ag leakage, but also shows high durability with unchanged efficacy after challenging bacteria up to five times repeatedly. Therefore, this confined plasmonic-based antibacterial nanocomposite shows great potential as a safe therapeutic system for wound disinfection.
KW - antibacterial efficacy
KW - cytotoxicity
KW - in situ implanting
KW - indoor light
KW - organic heterojunctions
KW - plasmonic nanocomposites
UR - http://www.scopus.com/inward/record.url?scp=85120818978&partnerID=8YFLogxK
U2 - 10.1002/adtp.202100202
DO - 10.1002/adtp.202100202
M3 - Journal article
AN - SCOPUS:85120818978
SN - 2366-3987
VL - 5
JO - Advanced Therapeutics
JF - Advanced Therapeutics
IS - 2
M1 - 2100202
ER -